Patents Assigned to CURESTREAM CO., LTD.
  • Publication number: 20230381412
    Abstract: A blood glucose control system according to an embodiment of the present invention includes a continuous blood glucose meter configured to continuously measuring blood glucose of a patient, a bio-signal sensor configured to acquire a bio-signal of the patient, a lifelog data collector configured to collect lifelog data of the patient, an insulin injection controller configured to determine an insulin injection amount and an injection rate based on one or more of blood glucose measurement information and blood glucose metabolism characteristic information received from the continuous blood glucose meter, the bio-signal acquired by the bio-signal sensor or a stress level of the patient indexed by the bio-signal, and the lifelog data collected by the lifelog data collector, and an insulin pump configured to inject insulin into a body of the patient according to the insulin injection amount and the injection rate determined by the insulin injection controller.
    Type: Application
    Filed: October 26, 2020
    Publication date: November 30, 2023
    Applicants: CURESTREAM CO., LTD., POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION
    Inventors: Sung Min PARK, Gang Wook KIM